Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash
Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)
You may also like
Gainers
Latest Crypto News
"The Big Short" Michael Burry Reveals Short Position on Tesla
The probability of a 25 basis point interest rate cut by the Federal Reserve in December is 87.6%.
Powell did not comment on the economy and monetary policy in his Stanford University speech
The SEC Chairman will deliver a speech tonight at the NYSE, outlining the future vision of the U.S. capital markets
U.S. FDIC Acting Chair to Propose Stablecoin Regulation Framework in December
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Services:support@weex.com